Achieve Life Sciences, Inc.
ACHV
$2.36
-$0.04-1.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.21% | -47.88% | -30.29% | -18.59% | 22.96% |
| Total Depreciation and Amortization | 1.75% | 0.00% | 0.00% | 0.00% | -1.72% |
| Total Amortization of Deferred Charges | 55.56% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.04% | -3.79% | 8.74% | 84.48% | -48.43% |
| Change in Net Operating Assets | 722.22% | -88.64% | 324.63% | -1,071.01% | 3,350.00% |
| Cash from Operations | 11.41% | -110.77% | 6.94% | -21.17% | 15.03% |
| Capital Expenditure | -- | -- | -- | -- | 60.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.71% | 128.50% | -- | -- | -- |
| Cash from Investing | -11.71% | 128.50% | -- | -- | 60.00% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 272.68% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 108.41% | -5,201.96% | -100.27% | -- | -- |
| Foreign Exchange rate Adjustments | -200.00% | -- | -- | -- | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.57% | 89.91% | -201.61% | 1,262.18% | 15.12% |